In this issue:
- Second-line JAK inhibitor in UC
- Triglyceride-glucose index as a biomarker for IBD risk
- Functional profiling of a sulphide-reducing diet in UC
- NUDT15 genetic testing to prevent thiopurine-induced myelosuppression
- Appendicectomy for maintenance of remission in UC
- Appendicectomy for inducing remission in moderate-to severe UC
- Appendicectomy in patients with CD
- Durable remission after ileocolic resection for CD
- Surveying dietary beliefs of patients and clinicians in IBD
- JAK inhibitor-induced acne
- Science Blog: IBD and chronic kidney disease
Please login below to download this issue (PDF)